Ellipticine is a polyaromatic small molecule DNA intercalator, demonstrated to inhibit Topo II (DNA topoisomerase II) and to form covalent adducts with DNA. The formation of Ellipticine-DNA adducts is correlated to cytotoxicity and these adducts are suggested to interfere with DNA replication in the S phase. Antineoplastic effects are demonstrated with Ellipticine. Processing of Ellipticine by cytochrome p450 produces the adduct forming metabolites 13- and 12-hydroxyellipticine, and Ellipticine is described to inhibit cytochrome p450 CYP1A1 activity. Ellipticine was also shown to block p53 protein phosphorylation.
1. Froelich-Ammon, S.J., et al. 1995. J. Biol. Chem. 270: 14998-15004. PMID: 7797481
2. Ohashi, M., et al. 1995. Jpn. J. Cancer Res. 86: 819-827. PMID: 7591958
3. Chang, C.Y. and Puga, A. 1998. Mol. Cell. Biol. 18: 525-535. PMID: 9418899
4. Poljaková, J., et al. 2009. Biochem. Pharmacol. 77: 1466-1479. PMID: 19426684
See how others have used Ellipticine. Click on the entry to view the PubMed entry .
PMID: # 27769881 Siebert, MN. et al. 2017. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 203: 115-121.
PMID: # 28623690 Siebert, MN. et al. 2017. Aquat. Toxicol. 189: 142-149.
PMID: # 28555524 Wen, HL. et al. 2017. Immunopharmacol Immunotoxicol. 39: 219-224.
PMID: # 28498409 Kumarasamy, VM. et al. 2017. Int. J. Oncol. 51: 145-157.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.